Montanova Capital, LLC's Form 4 filing
Benitec Biopharma Inc. (BNTC) · filed Dec 29, 2025
- Accession no.
- 0000899140-25-001479
- Filed
- Dec 29, 2025, 7:31 PM ET
- Trade date
- Dec 23-29, 2025
- Filing delay
- 6 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.90M. It was filed 6 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Montanova Capital, LLCCIK 0001569064 | Director, 10% Owner |
| Averill Master Fund, Ltd.CIK 0001939329 | Director, 10% Owner |
| Averill Madison Master Fund, Ltd.CIK 0002021243 | Director, 10% Owner |
| Cowen AaronCIK 0001869640 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | Common stock, par value $0.0001 per share | PPurchaseAcquired | +42,600 | $12.85 | +$547,410 | 9,620,075 | Indirect | |
| Dec 23, 2025 | Common stock, par value $0.0001 per share | PPurchaseAcquired | +7,400 | $12.85 | +$95,090 | 1,834,053 | Indirect | |
| Dec 26, 2025 | Common stock, par value $0.0001 per share | PPurchaseAcquired | +14,320 | $13.10 | +$187,592 | 9,634,395 | Indirect | |
| Dec 26, 2025 | Common stock, par value $0.0001 per share | PPurchaseAcquired | +2,516 | $13.10 | +$32,959.6 | 1,836,569 | Indirect | |
| Dec 29, 2025 | Common stock, par value $0.0001 per share | PPurchaseAcquired | +65,800 | $13.44 | +$884,352 | 9,700,195 | Indirect | |
| Dec 29, 2025 | Common stock, par value $0.0001 per share | PPurchaseAcquired | +11,587 | $13.44 | +$155,729.28 | 1,848,156 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.